FIELD: medicine.
SUBSTANCE: expression Musashil is determined in the nuclei of epithelial and stromal cells of the foci of endometriosis and autologous endometrium. The results of immunohistochemical reaction are evaluated by semi-quantitative method in scores. When evaluating Musashil expression by 6 points, the recurrence of infiltrative pelvic endometriosis is diagnosed.
EFFECT: effective way to predict the recurrence of infiltrative pelvic endometriosis.
1 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREDICTION OF DEVELOPMENT OF COMMON FORMS OF INFILTRATIVE ENDOMETRIOSISS BASED ON EVALUATION OF CD15 EXPRESSION IN ENDOMETRIC BIOPSY MATERIALS | 2016 |
|
RU2634263C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING DEEP INFILTRATIVE ENDOMETRIOSIS IN WOMEN OF REPRODUCTIVE AGE | 2022 |
|
RU2775544C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF HIGHLY DIFFERENTIATED ENDOMETRIOID ADENOCARCINOMA OF CORPUS UTERI IN PATIENTS OF PERIMENOPAUSAL PERIOD | 2014 |
|
RU2561677C1 |
| METHOD FOR EARLY DIAGNOSIS OF NEOPLASTIC TRANSFORMATION OF ENDOMETRIOID OVARIAN CYSTS | 2020 |
|
RU2730952C1 |
| METHOD FOR PREDICTION OF RECURRENT ENDOMETRIOID OVARIAN CYSTS | 2018 |
|
RU2694882C1 |
| METHOD FOR PREDICTING THE RECURRENCE OF ENDOMETRIAL CYSTS AFTER SURGICAL TREATMENT BY MEANS OF IMMUNOHISTOCHEMICAL MARKERS | 2017 |
|
RU2681219C1 |
| METHOD FOR PREDICTING RECURRENCE OF ENDOMETRIOID OVARIAN CYSTS AFTER SURGICAL TREATMENT | 2021 |
|
RU2757236C1 |
| METHOD OF DETERMINING RISK OF RECURRENCE OF ENDOMETRIOID OVARIAN CYSTS AFTER SURGICAL TREATMENT | 2023 |
|
RU2811890C1 |
| METHOD FOR DETERMINING HYSTERECTOMY INDICATIONS IN ENDOMETRIUM HYPERPLASIA CASES | 2006 |
|
RU2310857C1 |
| N-ACETYL-L-CYSTEINE FOR TREATMENT OF ENDOMETRIOSIS | 2010 |
|
RU2549433C2 |
